Eris Lifesciences Ltd. is a high-risk pharmaceutical company based in India, specializing in branded pharmaceutical formulations for Lifestyle therapies like Diabetes Care, Cardiac Care, Nutrition, and Central Nervous System. With a Risk Rating Score of 30.7, Eris Lifesciences Ltd. operates in a single segment focusing on pharmaceuticals, offering brands such as Glimisave, Cyblex, Eritel, Atorsave, and Crevast.